OQS
FATE icon

Occudo Quantitative Strategies’s Fate Therapeutics FATE Stock Holding History

Occudo Quantitative Strategies’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-98,452
Closed -$561K – 1091
2023
Q1 		$561K Sell
98,452
-67,061
-41% -$405K 0.05% 481
2022
Q4 		$1.67M Buy
165,513
+127,062
+330% +$2.39M 0.19% 156
2022
Q3 		$862K Sell
38,451
-54,536
-59% -$1.58M 0.07% 463
2022
Q2 		$2.3M Buy
+92,987
New +$2.57M 0.19% 144
2021
Q2 		– Sell
-3,034
Closed -$250K – 938
2021
Q1 		$250K Sell
3,034
-2,731
-47% -$262K 0.05% 553
2020
Q4 		$524K Buy
+5,765
New +$358K 0.16% 227

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return